Envlo Tablet

DRUG2 trials

Sponsors

Daewoong Pharmaceutical Co. LTD.

Conditions

Diabetes Mellitus, Type 2Type 2 Diabetes Mellitus

Unknown Phase

Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus

Active, not recruitingNCT06427083

Daewoong Pharmaceutical Co. LTD.Type 2 Diabetes Mellitus

Start: 2024-06-11End: 2026-06-30Updated: 2025-09-02

Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia

RecruitingNCT06647888

Daewoong Pharmaceutical Co. LTD.Diabetes Mellitus, Type 2

Start: 2024-12-03End: 2026-06-30Target: 12000Updated: 2025-01-23